Aristo Bio Tech Lifescience Ltd vs Mahamaya Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aristo Bio-Tech & Lifescience Ltd is ₹ 115.9 as of 13 May 15:30 . The P/E Ratio of Aristo Bio-Tech & Lifescience Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Mahamaya Lifesciences Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Aristo Bio-Tech & Lifescience Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Mahamaya Lifesciences Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Revenue of Aristo Bio-Tech & Lifescience Ltd is ₹ 0 crore as of Dec '24 .The Revenue of Mahamaya Lifesciences Ltd is ₹ 0 crore as of Dec '24 . The EBITDA of Aristo Bio-Tech & Lifescience Ltd is ₹ 0 crore as of Dec '24 .The EBITDA of Mahamaya Lifesciences Ltd is ₹ 0 crore as of Dec '24 . The Net Profit of Aristo Bio-Tech & Lifescience Ltd is ₹ 0 crore as of Dec '24 .The Net Profit of Mahamaya Lifesciences Ltd is ₹ 0 crore as of Dec '24 . The Dividend Payout of Aristo Bio-Tech & Lifescience Ltd changed from 4.78 % on March 2023 to 8.39 % on March 2025 . This represents a CAGR of 20.63% over 3 yearsThe Dividend Payout of Mahamaya Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aristo Bio-Tech & Lifescience Ltd

Aristo Bio-Tech & Lifescience Limited was originally incorporated on March 17, 2005 as 'Aristo Bio-Tech and Lifescience Private Limited' with the Registrar of Companies, Maharashtra, Mumbai.
Subsequently Company converted into Public Limited Company and name of company was changed to 'Aristo Bio-Tech and Lifescience Limited' vide fresh Certificate of Incorporation dated May 20, 2020.
The Company came out with a Public Issue by allotting 18,12,800 Equity Shares of face value of Rs 10 each in January, 2023 by raising funds of Rs. 13.05 Cr. through Fresh Issue. Aristo Bio-Tech & Lifescience is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging and job work services in various Pesticides such as Insecticides, Herbicides, Fungicides, Plant Growth Regulators and other Agrochemicals.

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
The Company began the journey by focusing on import and registration of vital pesticide molecules.
It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.

FAQs for the comparison of Aristo Bio-Tech & Lifescience Ltd and Mahamaya Lifesciences Ltd

Which company has a larger market capitalization, Aristo Bio-Tech & Lifescience Ltd or Mahamaya Lifesciences Ltd?

Market cap of Aristo Bio-Tech & Lifescience Ltd is 78 Cr while Market cap of Mahamaya Lifesciences Ltd is 432 Cr

What are the key factors driving the stock performance of Aristo Bio-Tech & Lifescience Ltd and Mahamaya Lifesciences Ltd?

The stock performance of Aristo Bio-Tech & Lifescience Ltd and Mahamaya Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aristo Bio-Tech & Lifescience Ltd and Mahamaya Lifesciences Ltd?

As of May 18, 2026, the Aristo Bio-Tech & Lifescience Ltd stock price is INR ₹115.9. On the other hand, Mahamaya Lifesciences Ltd stock price is INR ₹185.0.

How do dividend payouts of Aristo Bio-Tech & Lifescience Ltd and Mahamaya Lifesciences Ltd compare?

To compare the dividend payouts of Aristo Bio-Tech & Lifescience Ltd and Mahamaya Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.